ATC Group: S01EA03 Apraclonidine

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of S01EA03 in the ATC hierarchy

Level Code Title
1 S Sensory organs
2 S01 Ophthalmologicals
3 S01E Antiglaucoma preparations and miotics
4 S01EA Sympathomimetics in glaucoma therapy
5 S01EA03 Apraclonidine

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
OPHTHALM - Ophthalmic 0.3 ml

Active ingredients in S01EA03

Active Ingredient Description
Apraclonidine

Apraclonidine is an α2-adrenergic receptor agonist and a weak α1-adrenergic receptor agonist. It is used for the prevention and treatment of postsurgical intraocular pressure elevation.

Related product monographs

Title Information Source Document Type  
Iopidine 0.5% Ophthalmic solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
IOPIDINE Eye drops, solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicines in this ATC group

United States (US)

Australia (AU)

Austria (AT)

Canada (CA)

Finland (FI)

France (FR)

Ireland (IE)

Israel (IL)

Malta (MT)

Netherlands (NL)

New Zealand (NZ)

Spain (ES)

Tunisia (TN)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.